The Current Status of BCG Vaccination in Young Children in South Korea
- PMID: 23227079
- PMCID: PMC3510289
- DOI: 10.4046/trd.2012.72.4.374
The Current Status of BCG Vaccination in Young Children in South Korea
Abstract
Background: Delivery of Bacille Calmette-Guréin (BCG) Tokyo vaccine, with the multipuncture device, has been much preferred over BCG Pasteur, with the intradermal method, possibly due to the easier manner of administration, a desire to avoid any trouble with scars, as well as side effects and higher profits to providers in South Korea.
Methods: To determine BCG scar status in 0~6 year old children vaccinated with two BCG vaccines (Pasteur BCG vaccine with intradermal method and BCG Tokyo vaccine with percutaneous method), the data from the national BCG scar survey in 2006 was analyzed.
Results: Based on the national survey, the high proportion that were vaccinated with BCG Tokyo vaccines with the multipuncture method (64.5%) was noted in 0~6 year old Korean children. From inspection of scar formation, as an indicator of vaccination, the median number of the visible pin scars from the percutaneous method was 16 (interquartile range, 12~18) in the Korean children, and pin scars decreased as the age of the children increased (p<0.001).
Conclusion: The findings in this survey clearly showed a growing preference of parents for the BCG Tokyo vaccines by the multipuncture method in South Korea.
Keywords: BCG Vaccine; Tuberculosis; Vaccination.
Figures
Similar articles
-
Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method.Thorax. 1999 Sep;54(9):762-4. doi: 10.1136/thx.54.9.762. Thorax. 1999. PMID: 10456967 Free PMC article. Clinical Trial.
-
The distribution and implications of BCG scars in northern Malawi.Bull World Health Organ. 1989;67(1):35-42. Bull World Health Organ. 1989. PMID: 2706726 Free PMC article.
-
BCG osteomyelitis caused by the BCG Tokyo strain and confirmed by molecular method.Vaccine. 2008 Aug 12;26(34):4379-81. doi: 10.1016/j.vaccine.2008.06.004. Epub 2008 Jun 20. Vaccine. 2008. PMID: 18603342
-
BCG scarring and improved child survival: a combined analysis of studies of BCG scarring.J Intern Med. 2020 Dec;288(6):614-624. doi: 10.1111/joim.13084. Epub 2020 May 25. J Intern Med. 2020. PMID: 32301189 Review.
-
BCG vaccination in India and tuberculosis in children: newer facets.Indian J Pediatr. 1994 Sep-Oct;61(5):451-62. doi: 10.1007/BF02751703. Indian J Pediatr. 1994. PMID: 7744445 Review.
Cited by
-
Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea.J Korean Med Sci. 2018 Dec 26;34(1):e3. doi: 10.3346/jkms.2019.34.e3. eCollection 2019 Jan 7. J Korean Med Sci. 2018. PMID: 30618511 Free PMC article.
-
The usefulness of interferon-gamma release assay for diagnosis of tuberculosis-related uveitis in Korea.Korean J Ophthalmol. 2014 Jun;28(3):226-33. doi: 10.3341/kjo.2014.28.3.226. Epub 2014 May 19. Korean J Ophthalmol. 2014. PMID: 24882956 Free PMC article.
-
BCG vaccination-induced suppurative lymphadenitis: four signs to pay attention to.Int Wound J. 2017 Dec;14(6):1385-1387. doi: 10.1111/iwj.12755. Epub 2017 Apr 19. Int Wound J. 2017. PMID: 28425207 Free PMC article.
-
Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area.Clin Rheumatol. 2014 Sep;33(9):1307-12. doi: 10.1007/s10067-013-2387-z. Epub 2013 Sep 22. Clin Rheumatol. 2014. PMID: 24057090
References
-
- Tan JS, Canaday DH, Boom WH, Balaji KN, Schwander SK, Rich EA. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol. 1997;159:290–297. - PubMed
-
- Kim HJ, Oh SY, Lee JB, Park YS, Lew WJ. Tuberculin survey to estimate the prevalence of tuberculosis infection of the elementary schoolchildren under high BCG vaccination coverage. Tuberc Respir Dis. 2008;65:269–276.
-
- Kim HJ, Oh SY, Lee JB. Report on Comparison of Each Strain (Pasteur, Danish, Tokyo) of BCG Efficacy Using Tuberculin Test and Adverse Reactions. Seoul: Korean Institute of Tuberculosis; 2008.
-
- Fine PE, Carneiro IA, Milstien JB, Clements CJ. Issues relating to the use of BCG immunization programmes. Report No. WHO/V&B/99.23. Geneva: World Health Organization; 1999.
-
- Gheorghiu M. The present and future role of BCG vaccine in tuberculosis control. Biologicals. 1990;18:135–141. - PubMed